COG6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.036400E-01
Normal-vs-Stage2
6.570000E-01
Normal-vs-Stage3
6.945800E-01
Normal-vs-Stage4
1.005190E-01
Stage1-vs-Stage2
2.001200E-01
Stage1-vs-Stage3
1.757240E-01
Stage1-vs-Stage4
9.169000E-01
Stage2-vs-Stage3
4.353600E-01
Stage2-vs-Stage4
2.279000E-01
Stage3-vs-Stage4
4.685900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.474200E-01
Normal-vs-AfricanAmerican
7.998000E-01
Normal-vs-Asian
8.534800E-01
Caucasian-vs-AfricanAmerican
7.172200E-01
Caucasian-vs-Asian
6.175800E-01
AfricanAmerican-vs-Asian
9.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.324200E-01
Normal-vs-Female
6.406800E-01
Male-vs-Female
4.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.878620E-01
Normal-vs-Age(41-60Yrs)
5.161200E-01
Normal-vs-Age(61-80Yrs)
7.346600E-01
Normal-vs-Age(81-100Yrs)
7.929200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.237800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.734800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.779000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.203800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.482800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.459200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.258400E-01
Normal-vs-Daily Drinker
6.250800E-01
Normal-vs-Weekly Drinker
7.987600E-01
Normal-vs-Occasional Drinker
3.533600E-01
Normal-vs-Social Drinker
1.951150E-01
Non Drinker-vs-Daily Drinker
1.965980E-01
Non Drinker-vs-Weekly Drinker
6.496000E-01
Non Drinker-vs-Occasional Drinker
4.583800E-02
Non Drinker-vs-Social Drinker
2.030600E-01
Daily Drinker-vs-Weekly Drinker
2.052200E-01
Daily Drinker-vs-Occasional Drinker
1.073800E-02
Daily Drinker-vs-Social Drinker
1.214400E-01
Weekly Drinker-vs-Occasional Drinker
1.704360E-01
Weekly Drinker-vs-Social Drinker
2.677400E-01
Occasional Drinker-vs-Social Drinker
6.668600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.432000E-01
Normal-vs-Grade 2
5.041600E-03
Normal-vs-Grade 3
1.922040E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.090400E-01
Grade 1-vs-Grade 3
3.747600E-01
Grade 1-vs-Grade 4
2.432000E-01
Grade 2-vs-Grade 3
7.514600E-01
Grade 2-vs-Grade 4
5.041600E-03
Grade 3-vs-Grade 4
1.922040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.900400E-01
Normal-vs-NonDiabetic
7.185200E-01
Diabetic-vs-NonDiabetic
5.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.363200E-01
Normal-vs-NoPancreatitis
6.932400E-01
Pancreatitis-vs-NoPancreatitis
3.084300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.135600E-01
Normal-vs-N1
6.573400E-01
N0-vs-N1
2.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.669600E-01
Normal-vs-TP53-NonMutant
5.451600E-02
TP53-Mutant-vs-TP53-NonMutant
4.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
